AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glitaray M 0.5 Tablet SR

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glitaray M 0.5 Tablet SR

Diabetease Duo 0.5mg Extended-Release tablets are antidiabetic medications combining two agents for adult type 2 diabetes management. They help regulate blood glucose. Administer this medication with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications like kidney disease, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol should be avoided due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require physician consultation. Regular blood glucose monitoring, along with blood cell and liver function tests, are recommended.

Primary Ingredients of Glitaray M 0.5 Tablet SR

No information provided. Therefore, no rephrased text can be given.

Uses of Glitaray M 0.5 Tablet SR

Managing type 2 diabetes

Major Benefits of Glitaray M 0.5 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glitaray M 0.5 Tablet SR should be administered with a meal.

Common Side effects of Glitaray M 0.5 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray M 0.5 Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glitaray M 0.5 Tablet SR with a meal.

How Glitaray M 0.5 Tablet SR works:

Glitaray M 0.5 SR tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose levels. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Glitaray M 0.5 SR Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaray M 0.5 Tablet SR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glitaray M 0.5mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glitaray M 0.5 Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glitaray M 0.5 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate hepatic dysfunction, a low initial dose is typically prescribed; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Glitaray M 0.5 Tablet SR :

Should you forget a dose of Glitaray M 0.5 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray M 0.5 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glitaray M 0.5 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glitaray M 0.5 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glitaray M 0.5 Tablet SR and seek immediate medical attention.
Glitaray M 0.5 Tablet SR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It helps control blood sugar when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 DM.
Glitaray M 0.5 Tablet SR may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged Glitaray M 0.5 Tablet SR use can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glitaray M 0.5 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glitaray M 0.5 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and increase the risk of lactic acidosis.
Glitaray M 0.5 Tablet SR
92
MRP 106
13% off